[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
November 2003

Endophthalmitis After Intravitreal Injection of Triamcinolone Acetonide

Arch Ophthalmol. 2003;121(11):1663-1664. doi:10.1001/archopht.121.11.1663-a

Intravitreal injections of triamcinolone acetonide have recently been used as treatment for various intraocular, neovascular, proliferative, or edematous diseases, such as diffuse diabetic macular edema, proliferative diabetic retinopathy, proliferative vitreoretinopathy, chronic prephthisical ocular hypotony, chronic uveitis, and persistent pseudophakic cystoid macular edema.14 In view of the enlarging therapeutic spectrum of use for intravitreal triamcinolone acetonide, the purpose of the present study was to evaluate the frequency of infectious endophthalmitis or sterile intraocular inflammation after the injection.5,6

First Page Preview View Large
First page PDF preview
First page PDF preview
×